Exact Mass: 343.204837

Exact Mass Matches: 343.204837

Found 105 metabolites which its exact mass value is equals to given mass value 343.204837, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Piperolein B

(8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one

C21H29NO3 (343.2147)


Minor constituent of Piper nigrum (black pepper). Piperolein B is found in herbs and spices and pepper (spice). Piperolein B is found in herbs and spices. Piperolein B is a minor constituent of Piper nigrum (black pepper

   

Isopiperolein B

(9E)-10-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)dec-9-en-1-one

C21H29NO3 (343.2147)


Isopiperolein B is found in herbs and spices. Isopiperolein B is an alkaloid from the berries of Piper nigrum (pepper). Alkaloid from the berries of Piper nigrum (pepper). Isopiperolein B is found in herbs and spices.

   

Dec-4-enedioylcarnitine

3-[(9-carboxynon-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H29NO6 (343.1995)


Dec-6-enedioylcarnitine is an acylcarnitine. More specifically, it is an dec-6-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Dec-6-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Dec-6-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Dec-5-enedioylcarnitine

3-[(9-carboxynon-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H29NO6 (343.1995)


Dec-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an dec-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Dec-5-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Dec-5-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z)-dec-2-enedioylcarnitine

3-[(9-carboxynon-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H29NO6 (343.1995)


(2Z)-dec-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z)-dec-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z)-dec-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z)-dec-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Dec-7-enedioylcarnitine

3-[(9-carboxynon-7-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H29NO6 (343.1995)


Dec-7-enedioylcarnitine is an acylcarnitine. More specifically, it is an dec-7-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Dec-7-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Dec-7-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z)-dec-4-enedioylcarnitine

3-[(9-carboxynon-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H29NO6 (343.1995)


(4Z)-dec-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an (4Z)-dec-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z)-dec-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4Z)-dec-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(1R,9S,10S)-17-[(3-Hydroxycyclobutyl)methyl]-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol

(1R,9S,10S)-17-[(3-Hydroxycyclobutyl)methyl]-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol

C21H29NO3 (343.2147)


   

1-(2,6-Dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane

[2-(3,4-dimethoxyphenyl)ethyl][1-(2,6-dimethylphenoxy)propan-2-yl]amine

C21H29NO3 (343.2147)


   

MONOAMINOILLIMAQUINONE

MONOAMINOILLIMAQUINONE

C21H29NO3 (343.2147)


   

Cyclosmenospongine

Cyclosmenospongine

C21H29NO3 (343.2147)


   

Daphniyunnine B

Daphniyunnine B

C21H29NO3 (343.2147)


   

(-)-Floridine

(-)-Floridine

C17H29NO6 (343.1995)


   
   
   
   

C-Profluorocurine

C-Profluorocurine

C20H27N2O3+ (343.2022)


   

CP-642931

CP-642931

C17H25N7O (343.212)


CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5447; ORIGINAL_PRECURSOR_SCAN_NO 5445 CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5458; ORIGINAL_PRECURSOR_SCAN_NO 5457 CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5487; ORIGINAL_PRECURSOR_SCAN_NO 5486 CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5483; ORIGINAL_PRECURSOR_SCAN_NO 5482 CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5482; ORIGINAL_PRECURSOR_SCAN_NO 5479 CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5493; ORIGINAL_PRECURSOR_SCAN_NO 5492 DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; INTERNAL_ID 292; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5493; ORIGINAL_PRECURSOR_SCAN_NO 5492

   

UNII-575702U55U

UNII-575702U55U

C21H29NO3 (343.2147)


   
   

2,4,6-Trideoxy-6-{[(4E)-3-hydroxy-2,4-dimethyl-4-heptenoyl]amino}-2,4-dimethylhex-5-ulosonic acid

2,4,6-Trideoxy-6-{[(4E)-3-hydroxy-2,4-dimethyl-4-heptenoyl]amino}-2,4-dimethylhex-5-ulosonic acid

C17H29NO6 (343.1995)


   

Hydroxybutorphanol

Hydroxybutorphanol

C21H29NO3 (343.2147)


   
   
   
   

piperchabamide F

piperchabamide F

C21H29NO3 (343.2147)


   
   

daphlongamine B

daphlongamine B

C21H29NO3 (343.2147)


   

N-allylschoberine|N16-allylisoschoberine

N-allylschoberine|N16-allylisoschoberine

C23H25N3 (343.2048)


   

(E)-2,4-Dimethoxy-3-(gammar,gammar-dimethylallylcinnamoyl)piperidide|2,4-dimethyoxy-3-gamma,gamma-dimethylallyl-trans-cinnamoylpiperidide

(E)-2,4-Dimethoxy-3-(gammar,gammar-dimethylallylcinnamoyl)piperidide|2,4-dimethyoxy-3-gamma,gamma-dimethylallyl-trans-cinnamoylpiperidide

C21H29NO3 (343.2147)


   

calycinumines A

calycinumines A

C21H29NO3 (343.2147)


   

5-epi-smenospongine

5-epi-smenospongine

C21H29NO3 (343.2147)


   
   
   
   
   

Smenospongine

Smenospongine

C21H29NO3 (343.2147)


   

(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one

NCGC00180733-02!(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one

C21H29NO3 (343.2147)


   

3-hydroxy-6-[[(E)-3-hydroxy-2,4-dimethylhept-4-enoyl]amino]-2,4-dimethyl-5-oxohexanoic acid

3-hydroxy-6-[[(E)-3-hydroxy-2,4-dimethylhept-4-enoyl]amino]-2,4-dimethyl-5-oxohexanoic acid

C17H29NO6 (343.1995)


   

(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one [IIN-based: Match]

NCGC00180733-02!(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one [IIN-based: Match]

C21H29NO3 (343.2147)


   

(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one [IIN-based on: CCMSLIB00000848139]

NCGC00180733-02!(E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one [IIN-based on: CCMSLIB00000848139]

C21H29NO3 (343.2147)


   

Undecyltyrazolone

Undecyltyrazolone

C21H29NO3 (343.2147)


   

3-hydroxy-6-[[(E)-3-hydroxy-2,4-dimethylhept-4-enoyl]amino]-2,4-dimethyl-5-oxohexanoic acid_major

3-hydroxy-6-[[(E)-3-hydroxy-2,4-dimethylhept-4-enoyl]amino]-2,4-dimethyl-5-oxohexanoic acid_major

C17H29NO6 (343.1995)


   

Piperolein B

(8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one

C21H29NO3 (343.2147)


   

Isopiperolein B

(9E)-10-(2H-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)dec-9-en-1-one

C21H29NO3 (343.2147)


   

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H26BNO4 (343.1955)


   

methyl 2-[[[3-(4-hydroxy-4-methylpentyl)-3-cyclohexen-1-yl]methylene]amino]benzoate

methyl 2-[[[3-(4-hydroxy-4-methylpentyl)-3-cyclohexen-1-yl]methylene]amino]benzoate

C21H29NO3 (343.2147)


   

1-TERT-BUTYL 4-ETHYL 4-(2-ETHOXY-2-OXOETHYL)PIPERIDINE-1,4-DICARBOXYLATE

1-TERT-BUTYL 4-ETHYL 4-(2-ETHOXY-2-OXOETHYL)PIPERIDINE-1,4-DICARBOXYLATE

C17H29NO6 (343.1995)


   

tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H26BNO4 (343.1955)


   

p-Diethylaminobenzaldehyde-N,N-diphenyl-hydrazone

p-Diethylaminobenzaldehyde-N,N-diphenyl-hydrazone

C23H25N3 (343.2048)


   

1-CBZ-6-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROPYRIDINE

1-CBZ-6-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROPYRIDINE

C19H26BNO4 (343.1955)


   

ethyl prop-2-enoate,2-methylaziridine,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid

ethyl prop-2-enoate,2-methylaziridine,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid

C17H29NO6 (343.1995)


   

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C19H26BNO4 (343.1955)


   

leerall / methyl anthranilate schiffs base

leerall / methyl anthranilate schiffs base

C21H29NO3 (343.2147)


   

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate

Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate

C19H26BNO4 (343.1955)


   

p-(Diethylamino)benzaldehyde diphenylhydrazone

p-(Diethylamino)benzaldehyde diphenylhydrazone

C23H25N3 (343.2048)


   

1-Boc-indole-4-boronic Acid Pinacol Ester

1-Boc-indole-4-boronic Acid Pinacol Ester

C19H26BNO4 (343.1955)


   

N,N,N,N-Tetramethylpararosaniline

N,N,N,N-Tetramethylpararosaniline

C23H25N3 (343.2048)


   

3-Hydroxybutorphanol

3-Hydroxybutorphanol

C21H29NO3 (343.2147)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

(1R)-1-(4-((2R,6S)-4-(4,6-Dimethyl-1,3,5-triazin-2-yl)-2,6-dimethylpiperazin-1-yl)pyrimidin-2-yl)ethanol

(1R)-1-(4-((2R,6S)-4-(4,6-Dimethyl-1,3,5-triazin-2-yl)-2,6-dimethylpiperazin-1-yl)pyrimidin-2-yl)ethanol

C17H25N7O (343.212)


   

2-(4-cyclohexylphenoxy)-N-(2-propyl-2H-tetrazol-5-yl)acetamide

2-(4-cyclohexylphenoxy)-N-(2-propyl-2H-tetrazol-5-yl)acetamide

C18H25N5O2 (343.2008)


   

Dec-4-enedioylcarnitine

Dec-4-enedioylcarnitine

C17H29NO6 (343.1995)


   

Dec-5-enedioylcarnitine

Dec-5-enedioylcarnitine

C17H29NO6 (343.1995)


   

Dec-7-enedioylcarnitine

Dec-7-enedioylcarnitine

C17H29NO6 (343.1995)


   

(2Z)-dec-2-enedioylcarnitine

(2Z)-dec-2-enedioylcarnitine

C17H29NO6 (343.1995)


   

(4Z)-dec-4-enedioylcarnitine

(4Z)-dec-4-enedioylcarnitine

C17H29NO6 (343.1995)


   

4-(Cyclohexylamino)-2-(3,5-dimethyl-1-pyrazolyl)-5-pyrimidinecarboxylic acid ethyl ester

4-(Cyclohexylamino)-2-(3,5-dimethyl-1-pyrazolyl)-5-pyrimidinecarboxylic acid ethyl ester

C18H25N5O2 (343.2008)


   

(2E)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoate

(2E)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodec-2-enoate

C18H31O6- (343.2121)


   

(E,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydodec-2-enoate

(E,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydodec-2-enoate

C18H31O6- (343.2121)


   

N-Acetylvalylleucylglycine methyl ester

N-Acetylvalylleucylglycine methyl ester

C16H29N3O5 (343.2107)


   

oscr#19(1-)

oscr#19(1-)

C18H31O6 (343.2121)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#19, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#19(1-)

ascr#19(1-)

C18H31O6 (343.2121)


Conjugate base of ascr#19

   

1-[(9E)-10-(3,4-methylenedioxyphenyl)-9-decenoyl]pyrrolidine

1-[(9E)-10-(3,4-methylenedioxyphenyl)-9-decenoyl]pyrrolidine

C21H29NO3 (343.2147)


A natural product found in Piper boehmeriaefolium.

   
   

3-[(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)methyl]-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

3-[(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)methyl]-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

C21H29NO3 (343.2147)


   

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-[(1s)-1-(acetyloxy)ethyl]-2,3-dihydroxy-3-methylbutanoate

(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethyl (2r)-2-[(1s)-1-(acetyloxy)ethyl]-2,3-dihydroxy-3-methylbutanoate

C17H29NO6 (343.1995)


   

(8s,11s,13e,14s,16s,17s,18r)-13-ethylidene-8,17-dihydroxy-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-trien-11-ium

(8s,11s,13e,14s,16s,17s,18r)-13-ethylidene-8,17-dihydroxy-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-trien-11-ium

[C20H27N2O3]+ (343.2022)


   

(1r,5r,8r,9s,11r,13r,14r,17r,18s,19s)-13,19-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-16-one

(1r,5r,8r,9s,11r,13r,14r,17r,18s,19s)-13,19-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-16-one

C21H29NO3 (343.2147)


   

(13z,14s,16r,17r)-13-ethylidene-16,17-dihydroxy-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-trien-11-ium

(13z,14s,16r,17r)-13-ethylidene-16,17-dihydroxy-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6-trien-11-ium

[C20H27N2O3]+ (343.2022)


   

4-(2-hydroxyethyl)-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

4-(2-hydroxyethyl)-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

C21H29NO3 (343.2147)


   

3-{[(1s,2r,4ar,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

3-{[(1s,2r,4ar,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

C21H29NO3 (343.2147)


   

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-2-methylbutyl]nona-2,8-dienimidic acid

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-2-methylbutyl]nona-2,8-dienimidic acid

C21H29NO3 (343.2147)


   

7,19-dihydroxy-14,18-dimethyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-4(20)-en-3-one

7,19-dihydroxy-14,18-dimethyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-4(20)-en-3-one

C21H29NO3 (343.2147)


   

20-(prop-2-en-1-yl)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

20-(prop-2-en-1-yl)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

C23H25N3 (343.2048)


   

3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

C21H29NO3 (343.2147)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one

C21H29NO3 (343.2147)


   

(2s,3r,4s)-6-{[(2r,3e,5r)-1,5-dihydroxy-2,4-dimethylhept-3-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

(2s,3r,4s)-6-{[(2r,3e,5r)-1,5-dihydroxy-2,4-dimethylhept-3-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

C17H29NO6 (343.1995)


   

3-{[(1r,2s,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

3-{[(1r,2s,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

C21H29NO3 (343.2147)


   

(2-{4,5-dimethoxy-2-[2-(4-methoxyphenyl)ethyl]phenyl}ethyl)dimethylamine

(2-{4,5-dimethoxy-2-[2-(4-methoxyphenyl)ethyl]phenyl}ethyl)dimethylamine

C21H29NO3 (343.2147)


   

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)nona-2,8-dienimidic acid

(2e,8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)nona-2,8-dienimidic acid

C21H29NO3 (343.2147)


   

(2s,3r,4s)-6-{[(2r,3r,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

(2s,3r,4s)-6-{[(2r,3r,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

C17H29NO6 (343.1995)


   

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)nona-2,8-dienimidic acid

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)nona-2,8-dienimidic acid

C21H29NO3 (343.2147)


   

(2r,3r,4s)-6-{[(2r,3s,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

(2r,3r,4s)-6-{[(2r,3s,4e)-1,3-dihydroxy-2,4-dimethylhept-4-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

C17H29NO6 (343.1995)


   

(2s,3r,4s)-6-{[(2r,3e,5s)-1,5-dihydroxy-2,4-dimethylhept-3-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

(2s,3r,4s)-6-{[(2r,3e,5s)-1,5-dihydroxy-2,4-dimethylhept-3-en-1-ylidene]amino}-3-hydroxy-2,4-dimethyl-5-oxohexanoic acid

C17H29NO6 (343.1995)


   

1-{6,9-dihydroxy-6,10-dimethyl-9-phenyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-5-yl}ethanone

1-{6,9-dihydroxy-6,10-dimethyl-9-phenyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-5-yl}ethanone

C21H29NO3 (343.2147)


   

1-[(1s,4s,5s,6r,8s,9s,10r)-6,9-dihydroxy-6,10-dimethyl-9-phenyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-5-yl]ethanone

1-[(1s,4s,5s,6r,8s,9s,10r)-6,9-dihydroxy-6,10-dimethyl-9-phenyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-5-yl]ethanone

C21H29NO3 (343.2147)


   

3-{[(1s,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

3-{[(1s,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-2-hydroxycyclohexa-2,5-diene-1,4-dione

C21H29NO3 (343.2147)


   

(1s,7s,10s,14s,15r,18s,19r)-7,19-dihydroxy-14,18-dimethyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-4(20)-en-3-one

(1s,7s,10s,14s,15r,18s,19r)-7,19-dihydroxy-14,18-dimethyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icos-4(20)-en-3-one

C21H29NO3 (343.2147)


   

(1s,9s,13s,14r,16r,17s)-4-(2-hydroxyethyl)-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

(1s,9s,13s,14r,16r,17s)-4-(2-hydroxyethyl)-13,17-dimethyl-11-azapentacyclo[12.3.1.0¹,⁵.0⁹,¹⁷.0¹¹,¹⁶]octadec-4-ene-6,18-dione

C21H29NO3 (343.2147)


   

(1s,15r,16s,21r)-20-(prop-2-en-1-yl)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

(1s,15r,16s,21r)-20-(prop-2-en-1-yl)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

C23H25N3 (343.2048)


   

13,19-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-16-one

13,19-dihydroxy-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-16-one

C21H29NO3 (343.2147)


   

10-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)dec-9-en-1-one

10-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)dec-9-en-1-one

C21H29NO3 (343.2147)


   

(2e,8e,10z)-12-(1,6-dihydropyridin-2-yl)-7-hydroxy-2,6,6,10-tetramethyl-12-oxododeca-2,8,10-trienal

(2e,8e,10z)-12-(1,6-dihydropyridin-2-yl)-7-hydroxy-2,6,6,10-tetramethyl-12-oxododeca-2,8,10-trienal

C21H29NO3 (343.2147)


   

hexahydro-1h-pyrrolizin-1-ylmethyl 3-(acetyloxy)-2-hydroxy-2-(2-hydroxypropan-2-yl)butanoate

hexahydro-1h-pyrrolizin-1-ylmethyl 3-(acetyloxy)-2-hydroxy-2-(2-hydroxypropan-2-yl)butanoate

C17H29NO6 (343.1995)


   

3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-4-hydroxycyclohexa-3,5-diene-1,2-dione

3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-amino-4-hydroxycyclohexa-3,5-diene-1,2-dione

C21H29NO3 (343.2147)